// startup autopsy

Norak Biosciences

Receptor science without a cure for cash burn

marketfitSilent Shutdown

Quiet closure with no public announcement · Fatal mistake: Norak failed to establish pharma licensing deals before its $13M runway expired, leaving it without a commercial anchor.

Founded	1999
Closed	2004
Country	USA
Sector	Biotech

50%

Key Events Timeline

1999-01-01

FOUNDING

Norak Biosciences founded in the USA to pursue receptor biology drug discovery research.

2001-06-01

FUNDING

Raised approximately $13M across early funding rounds to fuel receptor biology research programs.

2002-12-01

PRODUCT LAUNCH

Last funding activity recorded; no licensing deals or drug candidates advanced to clinical stage.

2004-06-01

SHUTDOWN

Norak Biosciences quietly ceased operations after exhausting capital with no commercial product or acquisition outcome.

Full Analysis

Analyst plan

Documented cause

Norak Biosciences failed to translate early-stage receptor biology research into viable drug candidates. With $13M raised and no commercial products, the company faced a fundamental challenge in moving from bas...

ic science to clinical development. Mounting R&D costs combined with inability to secure partnership deals drained capital faster than scientific milestones could justify continued funding. The biotec

Verified lesson

“...”

Unlock full lesson →

€15.6M

Peak valuation

HypeCycle · MoatType · ResearchTags

Norak Biosciences raised €13M before norak failed to establish pharma licensing deals before its $13m runway expired, leaving it without a commercial anchor. ended it. See the documented cause, verified lesson and all failure signals.

Unlock full analysis →Create free account

See all plans·Analyst plan — €149/mo